Haemonetics Corporation

75.24-41.73-35.68%Vol 5.78M1Y Perf -29.35%
Apr 19th, 2021 15:29 DELAYED
BID75.19 ASK75.30
Open91.94 Previous Close116.97
Pre-Market95.02 After-Market-
 -21.95 -18.77%  - -
Target Price
153.80 
Analyst Rating
Moderate Buy 1.67
Potential %
102.58 
Finscreener Ranking
★★+     49.29
Insiders Trans % 3/6/12 mo.
-100/-100/-92 
Value Ranking
★★★     50.84
Insiders Value % 3/6/12 mo.
-100/-100/-92 
Growth Ranking
★★★★     62.56
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-90 
Income Ranking
 —    -
Market Cap3.82B 
Earnings Rating
Buy
Price Range Ratio 52W %
1.68 
Earnings Date
4th May 2021

Today's Price Range

74.1093.74

52W Range

74.10142.11

5 Year PE Ratio Range

-75.40141.60

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
-0.08%
1 Month
-1.72%
3 Months
-6.95%
6 Months
24.73%
1 Year
-29.35%
3 Years
55.34%
5 Years
242.02%
10 Years
247.56%

TickerPriceChg.Chg.%
HAE75.24-41.7300-35.68
AAPL134.280.12000.09
GOOG2 298.000.24000.01
MSFT258.38-2.3600-0.91
XOM56.19-0.4700-0.83
WFC43.950.11000.25
JNJ162.570.33000.20
FB300.94-5.2400-1.71
GE13.420.03000.22
JPM152.81-0.4900-0.32
Financial StrengthValueIndustryS&P 500US Markets
1.70
3.40
0.29
0.43
9.30
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
48.60
15.50
25.80
5.70
14.02
RevenueValueIndustryS&P 500US Markets
645.43M
12.70
-6.59
-2.54
Earnings HistoryEstimateReportedSurprise %
Q03 20210.680.8119.12
Q02 20210.500.6224.00
Q01 20210.410.4612.20
Q04 20200.730.69-5.48
Q03 20200.760.9423.68
Q02 20200.720.8720.83
Q01 20200.630.8128.57
Q04 20190.550.6110.91
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.690.00-
3/2021 FY2.585.31Positive
6/2021 QR0.762.70Positive
3/2022 FY3.612.85Positive
Next Report Date4th May 2021
Estimated EPS Next Report0.69
Estimates Count4
EPS Growth Next 5 Years %10.00
Volume Overview
Volume5.78M
Shares Outstanding50.82M
Trades Count56.02K
Dollar Volume35.93M
Avg. Volume461.46K
Avg. Weekly Volume1.27M
Avg. Monthly Volume636.13K
Avg. Quarterly Volume497.22K

Haemonetics Corporation (NYSE: HAE) stock closed at 116.97 per share at the end of the most recent trading day (a -1.34% change compared to the prior day closing price) with a volume of 156.94K shares and market capitalization of 3.82B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3004 people. Haemonetics Corporation CEO is Christopher A. Simon.

The one-year performance of Haemonetics Corporation stock is -29.35%, while year-to-date (YTD) performance is -1.5%. HAE stock has a five-year performance of 242.02%. Its 52-week range is between 74.1 and 142.11, which gives HAE stock a 52-week price range ratio of 1.68%

Haemonetics Corporation currently has a PE ratio of 53.70, a price-to-book (PB) ratio of 8.04, a price-to-sale (PS) ratio of 9.18, a price to cashflow ratio of 37.90, a PEG ratio of 2.32, a ROA of 8.11%, a ROC of 12.26% and a ROE of 16.08%. The company’s profit margin is 14.02%, its EBITDA margin is 25.80%, and its revenue ttm is $645.43 Million , which makes it $12.70 revenue per share.

Of the last four earnings reports from Haemonetics Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.69 for the next earnings report. Haemonetics Corporation’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Haemonetics Corporation is Moderate Buy (1.67), with a target price of $153.8, which is +102.58% compared to the current price. The earnings rating for Haemonetics Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Haemonetics Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Haemonetics Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 11.84, ATR14 : 4.21, CCI20 : 107.45, Chaikin Money Flow : -0.03, MACD : -2.96, Money Flow Index : 63.03, ROC : 4.09, RSI : 38.08, STOCH (14,3) : 71.86, STOCH RSI : 0.54, UO : 45.10, Williams %R : -28.14), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Haemonetics Corporation in the last 12-months were: Charles J. Dockendorff (Option Excercise at a value of $432 420), Charles J. Dockendorff (Sold 12 180 shares of value $1 638 575 ), Christopher A. Simon (Sold 56 029 shares of value $4 956 801 ), Christopher Simon (Sold 1 008 shares of value $101 244 ), Dan Goldstein (Option Excercise at a value of $189 426), Dan Goldstein (Sold 8 746 shares of value $925 972 ), Jacqueline Scanlan (Option Excercise at a value of $120 298), Jacqueline Scanlan (Sold 15 943 shares of value $1 441 829 ), Josep Llorens (Sold 208 shares of value $19 707 ), Michelle L. Basil (Sold 25 673 shares of value $2 321 495 ), Richard J. Meelia (Option Excercise at a value of $367 557), Richard J. Meelia (Sold 10 353 shares of value $1 393 927 ), Robert E. Abernathy (Buy at a value of $647 440), William P. Burke (Sold 24 552 shares of value $2 225 558 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (50.00 %)
3 (60.00 %)
Moderate Buy
2 (33.33 %)
2 (33.33 %)
2 (40.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.40

Haemonetics Corporation

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.

CEO: Christopher A. Simon

Telephone: +1 781 848-7100

Address: 125 Summer Street, Boston 02110, MA, US

Number of employees: 3 004

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

Bearish Bullish

52%48%

News

Stocktwits